Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins.
In vivo perfusion of canine testes with ketoconazole inhibited the stimulation of testosterone production by human chorionic gonadotropin in a dose-dependent manner. Ketoconazole also selectively displaced steroids from serum-binding globulins. Dihydrotestosterone and estradiol binding to sex hormone-binding globulin were inhibited by ketoconazole. Cortisol binding to corticosteroid-binding globulin was unaffected. The concentrations of ketoconazole that inhibited human chorionic gonadotropin stimulation of testicular androgen production and displaced sex steroids from sex hormone-binding globulin were in the range of blood levels found in patients on higher therapeutic dosage regimens. Suppression of testicular testosterone synthesis and displacement of estrogens from sex hormone-binding globulin may decrease the androgen/estrogen ratio of the blood and contribute to the development of gynecomastia that has been reported in some ketoconazole-treated patients.
D000818:Animals; D000935:Antifungal Agents / Q000009:adverse effects*; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000378:metabolism; D004285:Dogs; D012739:Gonadal Steroid Hormones / Q000378:metabolism*; D006177:Gynecomastia / Q000139:chemically induced; D007093:Imidazoles / Q000009:adverse effects* / Q000378:metabolism; D007654:Ketoconazole; D008297:Male; D010879:Piperazines / Q000009:adverse effects* / Q000378:metabolism; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism*; D013737:Testis / Q000187:drug effects* / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism*
D000935:Antifungal Agents; D006063:Chorionic Gonadotropin; D012739:Gonadal Steroid Hormones; D007093:Imidazoles; D010879:Piperazines; D012738:Sex Hormone-Binding Globulin; D013196:Dihydrotestosterone; D013739:Testosterone; D007654:Ketoconazole